Medical/Pharmaceuticals

POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

GUANGZHOU, China, March 13, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases inChina, today announced a strategic upgrade centered on the core track of "artificial intelligence ("AI") + medical-gra...

2026-03-13 20:00 4057

Esaote at EAU 2026: Introducing Exclusive PAM Technology to Advance Precision in Urological Imaging

The technology is available on the new MyLab™E85 GTS Edition that will be showcased together with the brand new MyLab™C30 GTS ultrasound system at the Esaote booth LONDON, March 13, 2026 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging - ultrasound, dedicated magnetic...

2026-03-13 19:00 3458

Everest Medicines' Licensing Partner NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study

* VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 inhibitor * Topline Phase 2a data show VIS-101 provides rapid, robust and durable treatment responses in wet AMD * VIS-101 demonstrated mean BVCA improvements of >10 ETDRS let...

2026-03-13 18:05 4347

Aphranel Named to Forbes China Beauty 100 List

SHANGHAI, March 12, 2026 /PRNewswire/ -- Aphranel, a China-origin regenerative medical aesthetics brand under the companySHANGHAI MOYANG BIOTECHNOLOGY, has been named to the Third Forbes China Beauty 100 list, published byForbes China, which recognizes brands in China's beauty and medical aesthet...

2026-03-13 11:23 2828

WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation

SINGAPORE, March 12, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two individual leadership awards at the 2026 Asia-Pacific Biopharma Excelle...

2026-03-13 11:09 3589

Alphamab Oncology Announces IND Application for Innovative EGFR/HER3 Dual Payload Bispecific ADC JSKN021 was Officially Accepted by CDE

SUZHOU, China, March 13, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative dual payload bispecific antibody-drug conjugate (ADC) targeting EGFR and HER3, has been officially...

2026-03-13 09:53 4174

PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement

— Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI — TOKYO, March 12, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboratio...

2026-03-13 08:00 2731

Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement

SINGAPORE, March 12, 2026 /PRNewswire/ -- Emerald Clinical Trials , a leading global clinical research organization (CRO), today announced it has been named a wi...

2026-03-12 21:02 3415

ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026

* Conducting global licensing partnering of LMT15, a proprietary BBB Shuttle platform * Also discussing global out-licensing of Phase 2 stage new drugs PF1801 and PF1804 SEOUL, South Korea, March 12, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd. , a biopharmaceutical company developing treatments...

2026-03-12 16:58 3579

Nuance Pharma Announces Approval of Ohtuvayre® (ensifentrine) in Hong Kong SAR, China

Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, further expanding access to COPD patients in select Special Administrative Regions (SARs) in Greater China SHANGHAI, March 12, 2026 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announced that the H...

2026-03-12 15:52 2863

Building Resilient Rare Disease Support in Malaysia with Pharm-D Health Science's VALENS Specialised Nutrition

KUALA LUMPUR, Malaysia, March 12, 2026 /PRNewswire/ -- As Malaysia commemorates National Rare Disease Day and marks the launch of the National Policy for Rare Diseases, long-term, sustainable care for individuals living with rare, complex genetic conditions is now gaining growing attention and in...

2026-03-12 10:14 4846

Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office

New Tokyo office strengthens local partnerships, regulatory alignment and global integrations in the world's third largest pharmaceutical market BETHESDA, Md., March 12, 2026 /PRNewswire/ -- Precision for Medicine (Precision), a global leader in biomarker-driven clinical research and development...

2026-03-12 07:50 3023

Sky Labs Launches their support of the American Heart Association's 'Established Investigator Award for Clinical Hypertension'

SEOUL, South Korea, March 12, 2026 /PRNewswire/ -- Sky Labs announced on 12th that it is supporting the Established Investigator Award for Clinical Hypertension' developed by the American Heart Association (the Association). This support follows a Memorandum of Understanding (MoU) signed with t...

2026-03-12 07:30 3168

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

WUXI, China, March 12, 2026 /PRNewswire/ -- LabConnect, a leading provider of technology-drivencentral laboratory services and...

2026-03-12 00:35 3301

Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics

From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence. TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the leading br...

2026-03-11 23:40 4809

IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent

ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc ., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT®, the ...

2026-03-11 21:38 4683

Ulike Announces Official Partnership with the PCOS Awareness Association (PCOSAA)

NEW YORK, March 11, 2026 /PRNewswire/ -- Millions of women worldwide live with Polycystic Ovary Syndrome (PCOS), a complex hormonal condition that remains widely underdiagnosed, stigmatized, and misunderstood. Beyond its medical implications, PCOS often affects mental health, self-esteem, and dai...

2026-03-11 21:00 3103

HelpMeSee Featured in "Healthier Together," Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training

NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together

2026-03-11 20:09 3394

GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain, 'MAV/06'

* Demonstrates effectiveness comparable to the global standard Oka strain vaccine YONGIN, South Korea, March 11, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that a review paper comprehensively analyzing the safety...

2026-03-11 13:50 3803

Haier Biomedical Hosts European Partner Summit in Rome and Advances "In Europe, for Europe" Strategy

ROME, March 11, 2026 /PRNewswire/ -- Haier Biomedical recently convened its European Partner Summit in Rome under the theme "Advancing Together - Sharing the Future of Biomedical Innovation," which brought together 37 regional partners and industry leaders fro...

2026-03-11 12:29 4543
1 ... 567891011 ... 646